论文部分内容阅读
目的当临床和(或)组织学评估不确定时,应用MRI确定新诊断子宫癌的起源部位(宫体或宫颈)的价值。材料与方法获机构伦理委员会同意,并免除符合HIPAA法案
Objectives To determine the value of a newly diagnosed uterine cancer origin (uterine or cervical) using MRI when the clinical and / or histological assessment is uncertain. Materials and Methods Approved by Institutional Ethics Committee and Exempted from HIPAA Act